Piracetam Sodium Chloride Injection

1. Pharmacology This product is a brain metabolism improving drug, which is a cyclic derivative of γ-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitation, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improvement effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability. 2. Toxicology The acute toxicity test of animal experiments showed that mice were given a gavage dose of more than 10g/kg without death. The median lethal dose LD50 of intravenous administration is 9.2g/kg. Subacute and chronic toxicity experiments did not find any adverse effects on the growth and development of rats and dogs. It has no effect on important internal organs and functions such as blood, heart, liver, kidney, and brain.

The main ingredient of this product is piracetam. Its chemical name is: 2-oxido-1-pyrrolidinoacetamide. Excipients: sodium chloride, water for injection.

This product is a colorless clear liquid.

Used to treat increased intracranial pressure caused by brain trauma.

For reducing intracranial pressure: intravenous drip, 16-20 g at a time, drip in 5-10 minutes, drip once every 6-8 hours, continuous medication for 3-5 days or as directed by the doctor.

Reactions may include dry mouth, loss of appetite, urticaria, and memory loss. Excitement, irritability, dizziness, headache, and insomnia are rare, and mild elevation of aminotransferase is occasionally seen.

1. Pregnant women and lactating women are prohibited from using this product. 2. Premature infants and newborns are prohibited from using this product. 3. Patients with extrapyramidal diseases and Huntington's chorea are prohibited from using this product. 4. Patients who are allergic to the ingredients of this product are prohibited from using this product.

When this product is used in combination with warfarin, it can prolong the prothrombin time and induce the inhibition of platelet aggregation. In patients receiving anticoagulant therapy, special attention should be paid to the coagulation time when piracetam is used at the same time to prevent the risk of bleeding, and the dosage and usage of the anticoagulant therapy should be adjusted.

Keep away from light and store in a sealed container.

250ml: Piracetam 8g and sodium chloride 2.25g

Cisen Pharmaceutical Co., Ltd.

• Founded in:

  1998-11-06

• Address:

  Tongji Science and Technology Industrial Park, Jining High-tech Zone

• Tax NO.:

  91370800706117999P

• Registered Funds:

  452,754,129 yuan

• Website:

  Log in to view

• Email:

  Log in to view